Lisdexamfetamine Dimesylate Tablet, Chewable
Brand names: Lisdexamfetamine Dimesylate, Vyvanse
Category: Psychiatry
FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Jul 14, 2023 (in shortage 3 years 2 months) · 3 manufacturers, 18 listed presentations
As of Sep 18, 2026, the FDA lists Lisdexamfetamine Dimesylate Tablet, Chewable as currently in shortage. Of 18 manufacturer presentations, 18 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) NDC 72205-132-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) NDC 57664-083-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) NDC 59417-115-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) NDC 72205-133-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) NDC 57664-084-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) NDC 59417-116-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) NDC 72205-134-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) NDC 57664-085-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) NDC 59417-117-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) NDC 72205-135-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) NDC 57664-086-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) NDC 59417-118-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) NDC 72205-136-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) NDC 57664-087-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) NDC 59417-119-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) NDC 72205-137-91 |
Novadoz Pharmaceuticals LLC | Available | - |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) NDC 57664-088-88 |
Sun Pharmaceutical Industries, Inc. | Available | - |
| Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) NDC 59417-120-01 |
Takeda Pharmaceuticals USA Inc. | Available | - |
Related medications in shortage
Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Lisdexamfetamine Dimesylate Tablet, Chewable (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Lisdexamfetamine Dimesylate Tablet, Chewable. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/lisdexamfetamine-dimesylate-tablet-chewable.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).